Cardinal Health Files Annual Report as Q4 Earnings Loom
The healthcare distributor submitted its 10-K filing to regulators, with fourth-quarter results scheduled for release later today.
Annual Filing Marks Fiscal Year-End
Cardinal Health, Inc. (CAH) filed its annual report on Form 10-K with the Securities and Exchange Commission on August 11, 2026, according to SEC EDGAR filings. The Dublin, Ohio-based healthcare services and products distributor is set to report its fourth-quarter fiscal 2026 results later today, followed by an earnings call with analysts and investors.
The company, which maintains a market capitalization of approximately $56 billion with shares last closing at $237.18, operates as one of the nation's largest pharmaceutical and medical product distributors, serving pharmacies, hospitals, and healthcare facilities across the United States.
Earnings Release Scheduled
According to MarginX data, Cardinal Health is scheduled to release its Q4 2026 financial results on August 11, 2026, with a corresponding earnings call planned for the same day. The timing of the 10-K filing aligns with the company's fiscal year-end reporting obligations and precedes the quarterly earnings announcement.
The annual report provides comprehensive disclosure of the company's financial performance, risk factors, and operational details for the full fiscal year, offering investors and analysts a complete picture of Cardinal Health's business performance.
Recent Insider Activity
MarginX data shows recent insider stock awards at the company. Aaron E. Alt received an award of 58,738 shares, while Jessica L. Mayer was granted 46,992 shares and Deborah Weitzman received 54,823 shares. These equity awards are typically part of executive compensation packages designed to align management interests with shareholder value.
Broader Market Context
Investors will be monitoring Cardinal Health's results amid a dynamic macroeconomic environment, with the Federal Reserve's Federal Open Market Committee scheduled to announce rate decisions on September 16 and October 28, according to MarginX data. These monetary policy decisions could influence healthcare sector valuations and the company's financing costs going forward.
This article was generated by MarginX from public news on 2026-08-11. It is not investment advice.